← Eichor
Condition: Empagliflozin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Empagliflozin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Empagliflozin Reversal of Arterial StiffnEss in Aging
Phase 2/Phase 3 · 1 location(s) · University of Missouri-Columbia · NCT06506422Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipi
NA · 1 location(s) · Medanta, The Medicity, India · NCT06095492A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Hea
Phase 4 · 12 location(s) · Herlev and Gentofte Hospital · NCT06642272Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment
Phase 3 · 9 location(s) · Christian Schulze · NCT07038356Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
EARLY_Phase 1 · 1 location(s) · University of Minnesota · NCT06507657Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablet
Phase N/A · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07023172Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT06989723Randomized Trial of SGLT2i in Heart Transplant Recipients
Phase 4 · 6 location(s) · VA Office of Research and Development · NCT06625073Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
Phase 4 · 2 location(s) · Nabiqasim Industries (Pvt) Ltd · NCT06862739A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease
Phase 3 · 102 location(s) · Boehringer Ingelheim · NCT07107945Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment
Phase 3 · 1 location(s) · Collegium Medicum w Bydgoszczy · NCT05905965Empagliflozin Treatment in Kidney Transplant Recipients
Phase 4 · 5 location(s) · VA Office of Research and Development · NCT06013865EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients wit
Phase 2/Phase 3 · 1 location(s) · University of East Anglia · NCT06715449Empagliflozin in Patients With Cirrhosis and Ascites
Phase 2 · 1 location(s) · Yale University · NCT05726032Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
Phase 4 · 2 location(s) · China National Center for Cardiovascular Diseases · NCT06055452Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
Phase 4 · 1 location(s) · Fazaia Ruth Pfau Medical College · NCT06706791meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Phase 3 · 1 location(s) · University Health Network, Toronto · NCT05715814Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Phase 1 · 1 location(s) · McGill University · NCT06753994Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
NA · 1 location(s) · Karolinska Institutet · NCT05501483Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT06483074A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a
Phase 3 · 632 location(s) · Boehringer Ingelheim · NCT06935370Effect of Empagliflozin on Inflammation
Phase 4 · 1 location(s) · Hotel Dieu de France Hospital · NCT07292909EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
Phase 4 · 2 location(s) · National Taiwan University Hospital · NCT06249945Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Phase 2 · 1 location(s) · Abdelrahman Mahmoud · NCT07336797Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI
Phase N/A · 1 location(s) · Collegium Medicum w Bydgoszczy · NCT07231939Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub
Phase 4 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06021145Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left
Phase 3 · 8 location(s) · Central Hospital, Nancy, France · NCT05879276EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · 480 location(s) · Boehringer Ingelheim · NCT06531824the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
Phase 2 · 1 location(s) · Ain Shams University · NCT07692256
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.